Clinical Trials at Bodyline Medical Wellness Clinics

At Bodyline Medical Wellness Clinics, we are committed to advancing medical science and improving patient outcomes through innovative clinical research. With over 17 years of experience, CQC-regulated clinics, and a network of seven research-ready sites across the UK, Bodyline is a trusted partner for clinical trials in weight management, metabolic health, female health, men's health, and diabetes.

Our clinical trial programmes are designed to evaluate new treatments, improve existing therapies, and deliver real-world evidence (RWE) that shapes the future of healthcare.

Our Areas of Clinical Research

Medical Weight Loss & Obesity Trials

Bodyline is a leading UK provider of GLP-1 and GIP-based weight loss treatments, including Mounjaro (tirzepatide) and Wegovy (semaglutide). Our trials focus on:

• GLP-1 receptor agonists for obesity management
• Dual-agonist therapies for enhanced weight loss
• Lifestyle and medication combination studies
• Long-term safety and efficacy of weight loss injections

Clinical trials have shown up to 20–25% body weight reduction with Mounjaro and 15% with Wegovy, alongside improvements in blood sugar control and cardiovascular health.

Female Health Trials – Menopause & Hormone Therapy

Our bespoke M Plan supports women through perimenopause, menopause, and post-menopause. Current research areas include:

• Hormone Replacement Therapy (HRT) safety and efficacy
• Impact of personalised menopause care on quality of life
• Combination therapies for symptom management
• Long-term outcomes of bioidentical hormone treatments

Men's Health Trials – Low Testosterone & Metabolic Health

We conduct trials on testosterone replacement therapy (TRT) and related metabolic health interventions. Research areas:

• TRT impact on energy, mood, and cardiovascular health
• Combination therapies for men with obesity and low testosterone
• Diagnostic innovations for men's health screening

Diabetes & Metabolic Health Trials

Many of our obesity trials overlap with type 2 diabetes research, as GLP-1 and GIP medications were originally developed for diabetes management.
Current studies explore:

• Blood sugar control with GLP-1/GIP therapies
• Weight loss impact on diabetes remission
• Integrated care models for metabolic syndrome

Other Clinical Research

• Low Dose Naltrexone (LDN) for autoimmune and chronic conditions
• Advanced diagnostic tools for early detection of health risks
• Real-world evidence (RWE) studies for new wellness interventions

Why Partner with Bodyline for Clinical Trials?

• 7 UK-based research-ready sites
• GCP-trained clinical teams
• Large patient database for rapid recruitment
• CQC-regulated clinics rated "Good"
• Expertise in obesity, diabetes, female health, and men's health
• Remote and in-clinic trial capabilities

Join Our Clinical Trials

Are you a patient interested in participating or a pharma/CRO seeking a trusted research partner?
Contact Bodyline today to learn more about our ongoing and upcoming trials.